(PharmaNewsWire.Com, December 01, 2017 ) Radiotherapy is a painless treatment and is extensively used in cancer treatment. Radiotherapy is centred on the principle of damage of cancerous cells by destructing their DNA inside these cells by radiations. It slow down the growth of cancerous cells and is intended at providing comforting care to relieve the patient of symptoms.
The Europe radiotherapy market is driven by numeral factors like surge in the number of cancer patients, decrease in the cost of treatment in several developed areas, enormous government and non-government funds in Research and Development of cancer treatment and inclination for non-invasive techniques of treatment. In radiotherapy, harm to neighbouring healthy cells by the high dosage of radiation is a side-effect which could pose a risk for market growth. The several side-effects of radiation treatment such as fatigue, skin problems, nausea, fertility issues, hair loss, appetite loss, diarrhea could possibly obstruct radiotherapy devices market growth.
The Europe radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.
Based on geography the market is analysed under various regions namely, Germany, France, Italy, Spain and U.K. France is expected to grow at highest CAGR among the countries in European region during the forecast period from 2016-2021.
Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.
About Market Data Forecast Market Data Forecast is a well versed market research firm catering solutions in the fields of market research, business intelligence and consulting. With a profound knowledge about the global market activities coupled with a customized approach. We render services in the most gripping markets like healthcare, agriculture and food & Beverages
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
